Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 Cases (1994-2002)

Journal of the American Veterinary Medical Association

Volumn 225, Issue 3, 2004, Pages 401-408

  Kosanovich Cahalane, Alane ^a,e   Payne, Sarah ^a   Barber, Lisa G ^a   Duda, Lillian E ^b   Henry, Carolyn J ^c   Mauldin, Glenna E ^d   Frimberger, Angela E ^a   Cotter, Susan M ^a   Moore, Antony S ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d LOUISIANA STATE UNIVERSITY   (United States)

^e Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; LOMUSTINE; PREDNISONE; VINBLASTINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DOG DISEASE; FEMALE; INGUINAL REGION; MALE; MASTOCYTOMA; NONHUMAN; PERINEUM; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR RECURRENCE;

ANIMALS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; FEMALE; GROIN; MALE; MAST-CELL SARCOMA; NEOPLASM RECURRENCE, LOCAL; PERINEUM; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 3342967624     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2004.225.401     Document Type: Article

References (20)

1. Dorn CR, Taylor DON, Schneider R, et al. Survey of neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 1967;40:307-318.
2. Cohen D, Reif JS, Brodey RS, et al. Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Res 1974;34:2859-2868.
3. Priester WA. Skin tumors in domestic animals. Data from 12 United States and Canadian colleges of veterinary medicine. J Natl Cancer Inst 1973;50:457-466.
4. Bostock DE. The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 1973;14:27-41.
5. Patnaik AK, Ehler WJ, MacEwen EG. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984;21:496-474.
6. Tams TR, Macy DW. Canine mast cell tumors. Compend Contin Educ Pract Vet 1981;3:869-877.
7. World Health Organization. Consultation on the biological behavior and therapy of tumors of domestic animals. Geneva: World Health Organization, 1978.
8. Macy DW. Canine and feline mast cell tumors: biologic behavior, diagnosis, and therapy. Semin Vet Med Surg (Small Anim) 1986;1:72-83.
9. Cotchin E. Further observations on neoplasms in dogs, with particular reference to site of origin and malignancy. Br Vet J 1954;110:218-230.
10. Turrel JM, Kitchell BE, Miller LM, et al. Prognostic factors for radiation treatment of mast cell tumors in 85 dogs. J Am Vet Med Assoc 1988;193:936-940.
11. Al-Sarraf R, Mauldin GN, Patnaik AK, et al. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. J Vet Intern Med 1996;10:376-378.
12. LaDue T, Price GS, Dodge R, et al. Radiation therapy for incompletely resected canine mast cell tumors. Vet Radiol Ultrasound 1998;39:57-62.
13. Rassnick KM, Moore AS, Williams LE, et al. Treatment of canine mast cell tumors with CCNU (Lomustine). J Vet Intern Med 1999;13:601-605.
14. Thamm DH, Mauldin EA, Vail DM. Prednisone and vinblastine chemotherapy for canine mast cell tumor - 41 cases (1992-1997). J Vet Intern Med 1999;13:491-497.
15. Evans HE, deLahunta A. Miller's guide to the dissection of the dog. Philadelphia: WB Saunders Co, 1996;173-179.
16. Frimberger AE, Moore AS, LaRue SM, et al. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993). J Am Anim Hosp Assoc 1997;33: 320-324.
17. Weisse C, Shofer FS, Sorenmo K. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 2002;38:71-73.
18. Moore AS, London CA, Wood CA, et al. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. J Vet Intern Med 1999;13:395-398.
19. McCaw DL, Miller MA, Bergman PJ, et al. Vincristine therapy for mast cell tumors in dogs. J Vet Intern Med 1997;11:375-378.
20. Michels GM, Knapp DW, DeNicola DB, et al. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. J Am Anim Hosp Assoc 2002;38:458-466.